Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
07/2007
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007CA2435328C N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds
07/05/2007WO2007076306A1 Fluorinated compounds
07/05/2007WO2007074632A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP
07/05/2007WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
07/05/2007US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
07/05/2007US20070155748 N-sulfonyl-alpha-amino-acid derivatives
07/05/2007US20070155717 Amidines and derivatives thereof and pharmaceutical compositions containing them
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/05/2007US20070154927 Energy transfer dyes with enhanced fluorescence
07/05/2007US20070154924 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing
07/05/2007DE102005062986A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments
07/05/2007DE102005062608A1 Solution system based on molten ionic liquid e.g. imidazolium salt for dissolving carbohydrate e.g. starch, cellulose or derivative and regeneration e.g. for fiber production also contains water and/or other protic solvent
07/05/2007DE102005061430A1 Substituierte Imidazolin-Derivate Substituted imidazoline derivatives
07/05/2007CA2623250A1 Fluorinated compounds
07/04/2007EP1802605A1 Imidazole derivatives as vanilloid receptor ligands
07/04/2007EP1802583A1 Heterocyclic carbonyl compounds
07/04/2007EP1720838B1 Method for producing 4-nitroimidazole compound
07/04/2007EP1263735B1 Acid addition salts of imidazolidinones as reaction catalysts
07/04/2007EP0977750B1 Farnesyltransferase inhibiting quinazolinones
07/04/2007CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
07/04/2007CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
07/04/2007CN1990473A Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof
07/04/2007CN1989969A Cyclic protein tyrosine kinase inhibitors
07/04/2007CN1324012C TNF-alpha prodn. inhibitors
07/03/2007US7238695 Imidazolyl derivatives
07/03/2007US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties
07/03/2007US7238212 Imidazole compounds and use of these compounds for dyeing keratinous fibers
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
07/03/2007CA2147953C Vapor sterilization using a non-aqueous source of hydrogen peroxide
06/2007
06/28/2007WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
06/28/2007WO2007073300A1 Gaba-b receptor modulators
06/28/2007WO2007073299A1 Imidazoles as gaba-b receptor modulators
06/28/2007WO2007073298A1 Imidazole derivatives for the treatment of gastrointestinal disorders
06/28/2007WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives
06/28/2007WO2007072080A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
06/28/2007WO2007071728A1 Hydantoins with insulinotropic action
06/28/2007WO2007071452A1 Synephrine derivatives useful as anti-inflammatory agents
06/28/2007US20070149615 Ketone compounds and compositions for cholesterol management and related uses
06/28/2007US20070149541 Imidazole compounds
06/28/2007DE102005063244A1 Modifiziertes 2-Nitroimidazol-Derivat The modified 2-nitroimidazole derivative
06/28/2007DE102005062175A1 Detergent- or cleaning agent, useful e.g. in liquid or gel form for flushing toilets and hard surface cleaning, comprises cyclic aminal
06/28/2007DE102005062025A1 New 3-imidazolylmethyl-aniline derivatives, useful as developers for dyeing keratin fibers, specifically human hair, also new intermediate nitro compounds
06/28/2007DE102005060462A1 Biphenylcarboxamide Biphenylcarboxamides
06/28/2007CA2669503A1 Compounds and methods for thiol-containing compound efflux and cancer treatment
06/28/2007CA2634359A1 Synephrine derivatives useful as anti-inflammatory agents
06/28/2007CA2633351A1 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
06/28/2007CA2632021A1 Gaba-b receptor modulators
06/28/2007CA2632020A1 Imidazoles as gaba-b receptor modulators
06/28/2007CA2632016A1 Imidazole derivatives for the treatment of gastrointestinal disorders
06/27/2007EP1800679A2 Nonsedating A-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione
06/27/2007EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers
06/27/2007EP1799217A1 Compounds and methods of treating insulin resistance and cardiomyopathy
06/27/2007EP1366025B1 Agonists of beta-adrenoreceptors
06/27/2007EP1263738B1 Substituted benzoylcyclohexenones
06/27/2007EP1144366B1 3,4-disubstituted acylanilide derivatives and their use as androgen receptor suppressors
06/27/2007CN1989131A Substituted thiophene derivatives as anti-cancer agents
06/26/2007US7235690 Anthranilamides and methods of their use
06/26/2007US7235575 Guanidine mimics as factor Xa inhibitors
06/21/2007WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/21/2007WO2007069773A1 A pharmaceutical composition comprising an amide derivative
06/21/2007WO2007069542A1 Transition metal complex compound and organic electroluminescence device making use of the same
06/21/2007WO2007068474A1 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
06/21/2007WO2007042543A3 Imidazole derivatives and their use for modulating the gaba-a receptor complex
06/21/2007WO2007039821A3 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
06/21/2007WO2007039117A3 A process for the preparation of sartan derivatives and intermediates useful in such process
06/21/2007US20070142646 Method of preparing ionic liquids
06/21/2007US20070142645 Method for the production of n,n-carbonyldiazoles
06/21/2007US20070142642 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007DE102005060467A1 Carboxamide Carboxamides
06/21/2007DE102005060316A1 Verfahren zur Herstellung von Methionin A process for producing methionine
06/21/2007CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/21/2007CA2628159A1 (2,5-dioxoimidazolidin-1-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
06/20/2007EP1798222A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
06/20/2007EP1797884A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
06/20/2007EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
06/20/2007EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/20/2007EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
06/20/2007CN1984895A Synthesis and uses of synephrine derivatives
06/20/2007CN1984893A Method for producing onium salts with a low chloride content
06/20/2007CN1984872A Process for the preparation of an (hetero) arylamine
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321985C Tinidazole preparing process
06/14/2007WO2007006387A8 Onium-alkylsulfonate production method
06/14/2007US20070135645 Two-step process for preparation of guanidinium salts having an anion selected from sulfonate, sulfate, imide, methanide, carboxylate, phosphate, phosphinate, phosphonate, borate, thiocyanate, perchlorate, fluorosilicate or nitrate;1,3-dimethyl-2-chloroimidazolidinium nitrate; simplification
06/14/2007US20070135634 Fluorinating agent and method for producing fluorine-containing compound using the same
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/14/2007US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin
06/14/2007US20070135411 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/14/2007US20070134729 Novel antibacterial agents
06/13/2007EP1795579A1 Asphaltene dispersants for petroleum products
06/13/2007EP1795529A2 Process for producing N-(Hetero)Aryl-substituted nitrogen-containing heteroaryl compound
06/13/2007EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors
06/13/2007EP1794132A2 Process for production of 2-chloro-4-nitroimidazole